Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 28 of 31
Effectiveness of Parent-Child Interaction and Emotion Development Therapy in Treating Preschool Children With Depression
NCT00595283
A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With Effusion
NCT00546117
Analyzing Lung Tissue in People With and Without Chronic Obstructive Pulmonary Disease Who Are Undergoing Lung Transplantation
NCT00756522
Biomarkers and Genetic Factors Related to Emphysema
NCT00757120
PET/CT Study in the Diagnosis of Coronary Plaque
NCT00850473
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
NCT00540007
Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight
NCT00834652
Sex Steroids, Sleep, and Metabolic Dysfunction in Women
NCT00805207
Stereotactic Radiosurgery (SRS) for Spine Metastases
NCT00593320
Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients
NCT00501163
The Biologic Basis of Hernia Formation
NCT01099033
Analysis and Characterization of Biologic Implants
NCT01060046
Hemodynamic Measurements During Liver Transplantation
NCT00682110
CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography
NCT00500344
The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
NCT00941889
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
NCT00512252
Omega-3 Fatty Acids and Muscle Protein Synthesis
NCT00794079
Reinforced Staple Line on Leak Rate in Distal Pancreatectomy
NCT01359410
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
NCT00537823
Pilot Study of Hippocampal Function in Type 1 Diabetes Mellitus (T1DM)
NCT00918801
Single Photon Emission Computed Tomography (SPECT) Lymph Node Mapping
NCT00608920
Quantifying Airway Inflammation With Radiologic Tests
NCT00741013
The Natural History of Community-Associated MRSA Infections and Decolonization Strategies
NCT00513799
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
NCT00442507
Lenalidomide in Older Patients With Acute Myeloid Leukemia Without Chromosome 5q Abnormalities
NCT00546897
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
NCT00548418
A Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple Myeloma
NCT00429949
Achieving Energy Balance in Post Partum Teens
NCT01617486
Assessment of Progesterone Receptors in Breast Carcinoma by Positron Emission Tomography (PET) Using Fluoro Furanyl Norprogesterone (FFNP)
NCT00968409
A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy
NCT00608751
IMRT Tomotherapy for Esophagus Cancer
NCT00593723
Effect of Weight Loss and Exercise on Liver and Muscle Fat in Obese Elderly
NCT00779207
Comparison of Low and High Phytosterol Diets With Respect to Cholesterol Metabolism
NCT00860509
Evaluating a Blood Pressure Reduction and Weight Loss Program in a Low Income, Ethnically Diverse Population (The Be Fit, Be Well [BFBW] Study)
NCT00661817
Observational Study of Delayed Nausea and Vomiting
NCT00696280
A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma
NCT00545519
The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients
NCT00508885
Renal Transplantation With Immune Monitoring
NCT00419575
Treatment of Acute Sinusitis
NCT00377403
The Role of Cerebral Hemodynamics in Moyamoya Disease
NCT00629915
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
NCT00383266
A Phase I/II Trial of Stereotactic Body Radiation Therapy
NCT00591838
Ventrointermediate Nucleus (VIM DBS) and Working Memory
NCT00906412
Testing of Different Methods for Determining Whether Breast Cancer Has Spread to the Lymph Nodes
NCT00360152
A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes
NCT00384956
Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)
NCT00894465
Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status
NCT01931527
Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients
NCT01113099
Exercise Dose and Nonalcoholic Fatty Liver Disease
NCT00771108
Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery
NCT00329433
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.